Corbus Pharmaceuticals (CRBP) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
30 Jun, 2026Opening remarks and agenda
Meeting held remotely and chaired by the Chair of the Board, with introductions of key executives, legal counsel, and the independent accounting firm in attendance.
Only validated stockholders could ask questions, limited to three per person, with responses confined to germane topics.
Voting restricted to five proposals outlined in the proxy statement, as no additional shareholder proposals were submitted in advance.
Corporate governance
Quorum established with 14,134,370 shares present, exceeding the one-third threshold required.
Inspector of Elections appointed and certified, with all proxy materials and records to be filed with meeting minutes.
Board and executive committee updates
Six director nominees presented for election: Yuval Cohen, Rachelle Jacques, John Jenkins, Anne Altmeyer, Yong Ben, and Winston Kung.
Latest events from Corbus Pharmaceuticals
- Q2 2026 net loss rose to $35M on higher R&D; cash runway extends into 2028, more funding needed.CRBP
Q2 2026 - Lead oncology and obesity assets advance with strong clinical data and FDA-aligned pivotal plans.CRBP
Jefferies Global Healthcare Conference 2026 - Nectin-4 ADCs address a critical gap in HPV-positive oropharyngeal cancer with strong potential.CRBP
KOL event - CRB-701 shows 42.9% ORR in OPSCC and 34.4% in cervical cancer with strong safety profile.CRBP
Study update - CRB-701 and CRB-913 show promising efficacy and safety, with pivotal trials launching in 2026.CRBP
Corporate presentation - ASCO will showcase pivotal CRB-701 data and CRB-913 obesity results are expected late summer.CRBP
RBC Capital Markets Global Healthcare Conference 2026 - CRB-701 and CRB-913 show promising efficacy and safety, with pivotal data expected in 2026.CRBP
Corporate presentation - Q1 2026 net loss rose to $23M on higher R&D; cash runway may extend into 2028.CRBP
Q1 2026 - CEO and CFO receive new two-year agreements with updated salaries; no other proxy changes.CRBP
Proxy filing